PBIO - Pressure BioSciences, Inc.
Chart Events
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 0.9800 |
| Open | 1.0000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.9000 - 1.0000 |
| 52 Week Range | 0.7100 - 2.2000 |
| Volume | |
| Avg. Volume | 32,973 |
| Market Cap | 16.27M |
| Beta (5Y Monthly) | 0.71 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.0600 |
| Earnings Date | Aug 16, 2023 - Aug 21, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Related Research
ACCESSWIREPressure BioSciences Updates Forecast with Six Key Goals for June 2023 with Expected Multi-Million Dollar Growth Increments in FY 2023 and Beyond
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables, and specialty testing services to the worldwide biotherapeutics, nutraceuticals, cosmeceuticals, food and beverage, and other industries today highlighted the six key goals they expect to achieve during the month of June 2023, and discussed the significant financial impact
GlobeNewswireNew to The Street Signs Pressure BioSciences, Inc. To 12 Month TV Series, Agreement Includes Commercials and Billboard Ads
New to The Street Signs Pressure BioSciences, Inc. To 12 Month TV Series, Agreement Includes Commercials and Billboard Ads New to The Street, announces the signing of a 12-month contract for filming and broadcasting tailored interviews and commercials about Pressure BioSciences, Inc.(OTCQB: PBIO) ($PBIO) - https://www.pressurebiosciences.com/ & https://www.newtothestreet.com/ NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) -- FMW Media's business TV show, New to The Street, announces the signing of a 1
- ACCESSWIRE
Pressure BioSciences Announces Commercial Availability of Best-in-Class Nano-CBD Topical Spray, Featuring Lightning-Fast Action from PBI's UltraShear Processing
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables, and specialty testing services to the worldwide biotherapeutics nutraceuticals, cosmeceuticals, food and beverage, and other industries, and CBD Supply MD, one of the largest and best-known retail suppliers of CBD products in the multi-state mid-Atlantic region, today announced
- ACCESSWIRE
Pressure BioSciences, Inc. Q1 2023 Financial Results Achieve All-Time Quarterly Record
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a leader in the development and sale of broadly enabling, high pressure-based equipment, consumables, and specialty testing services to the worldwide biotherapeutics, nutraceuticals, cosmeceuticals, food & beverage, and other industries, today reported that record quarterly financial results for any fiscal quarter was achieved in the first quarter ended March 31, 2023.
ACCESSWIREPressure BioScience’s Pressure-Based Tech Is Ready To Spur Innovation And Growth In A Life Sciences Sector In Flux
Often considered recession-proof, the life sciences sector faced a surprising amount of uncertainty over the past few years with up to 80% of companies saying they've been negatively impacted by the macroeconomic conditions that have shaken markets around the world.
- ACCESSWIRE
Extended Consumer Testing Strongly Validates Market Transforming Speed and Dosing Efficiency of Pressure BioSciences UltraShear Processed Nano-THC Oral Spray
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or "Company") today announced results from additional consumer focus group testing of a THC Nanoemulsion Oral Spray designed for rapid, direct absorption through the cheeks.
- ACCESSWIRE
Pressure BioSciences Updates Rapid Progress on Limited Offering of Exclusive THC Licenses for Revolutionary UltraShear Nanoemulsion Processing Platform
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumable products, and specialty services to the life sciences, nutraceuticals, cosmeceuticals, and other industries today provided a progress update on their exciting April 21, 2023, announcement.
ACCESSWIREKeynotes, Educational Panels and 77 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 25-27, 2023 at the Horseshoe Hotel & Casino in Las Vegas, NV
Planet MicroCap presents the Planet MicroCap Showcase: VEGAS taking place on April 25-27, 2023, where 77 MicroCap public and private companies will be presenting at the Horseshoe Hotel & Casino in Las Vegas, NV.
- ACCESSWIRE
Pressure BioSciences Unveils Powerful THC Market Leapfrog Opportunity with Exclusive Licensing of Their Revolutionary UltraShear Nanoemulsion Processing Platform
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumable products, and specialty services to the life sciences, nutraceuticals, cosmeceuticals, and other industries today announced the Company's strategic decision to offer up to five exclusive licenses to their patented and powerful UltraShear Technology™ (UltraShear™ or UST™) platform
- ACCESSWIRE
Pressure BioSciences Announces Expansion into Strategic Manufacturing Facilities with Premier Process Technologies Company, Artisan Industries
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumable products, and specialty services to the life sciences field and Artisan Industries, Inc. ("Artisan"), a worldwide leader in providing purification and separation technologies for the process industries, today announced a strategic agreement between the companies.
- ACCESSWIRE
Pressure BioSciences, Inc. Reports Q4 and FY 2022 Financial Results, Provides Business Update, and Offers Guidance for a Strong 2023
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences and other industries, reported financial results for the fourth quarter and fiscal year ended December 31, 2022, provided a business update, and offered guidance for a strong 2023, beginning with record revenue in the 2023 first quarter.
- ACCESSWIRE
Pressure BioSciences, Inc. to Discuss Fiscal Year 2022 Financial Results and Provide 2023 Business Update and Guidance
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Fiscal Year 2022 financial results and to provide a business update.
- ACCESSWIRE
Pressure BioSciences and NutraLife Biosciences Renew Partnership for Development and Distribution of Next Generation Nutraceuticals
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences industry, and NutraLife Biosciences (OTC Markets: NLBS) ("NLBS"), a highly-respected manufacturer and distributor of nutraceuticals primarily sold on a direct-to-consumer basis, today announced they have renewed collaborative efforts initiated four years
- ACCESSWIRE
Pressure BioSciences Reports Fresh Sales Momentum for PBI Agrochem
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences and other industries, and its wholly-owned subsidiary PBI Agrochem, Inc. announced it has shipped and billed an initial $130,000 order for its potent, environmentally-responsible nematode control product.
- ACCESSWIRE
Pressure BioSciences Receives $1.5M Contract for UltraShear Nanoemulsified CBD
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences and other industries, and CBD Supply MD, one of the largest and best-known retail suppliers of CBD products in the multi-state mid-Atlantic region, today announced the execution and launch of a manufacturing and distribution agreement (the "Agreement").
GlobeNewswirePresenting on the Emerging Growth Conference on March 22 Register Now
MIAMI, March 21, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 52nd Emerging Growth Conference on March 22, 2023. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the conference here. Submit Questions for any of the presenting companies
- ACCESSWIRE
Pressure BioSciences Announces the Exchange of Over $10 Million of Debt into Equity
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences and other industries, today announced that the Company's largest shareholder has exchanged over $10 million of senior secured debt into unsecured preferred stock.
News DirectPressure BioSciences’ Breakthrough UltraShear Nanoemulsion Processing Could Help Revolutionize The Edible Cannabis Industry
By Rachael Green, Benzinga
- ACCESSWIRE
Pressure BioSciences Receives Record Nearly $600,000 Order for 16 PCT Instruments
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences and other industries, today announced entrance into an exclusive distribution agreement for the People's Republic of China ("Agreement") with PRS International Trade (Shanghai) Co., Ltd. ("PRS International").
- ACCESSWIRE
Pressure BioSciences and One World Products Announce Partnership in Development of CBD-Nanoemulsion Sports Performance/Recovery Drinks
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences industry, and One World Products, Inc. (OTCQB: OWPC) ("OWPC"), the largest Black-controlled, fully-licensed hemp and cannabis producer in Colombia, today announced they have entered into an active collaboration agreement ("Agreement") under which the two companies
- ACCESSWIRE
Pressure BioSciences Nanoemulsions Platform Forging Game-Changing Future for Cannabis Industry
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or "Company") today announced results from initial consumer focus group testing of a THC Nanoemulsion Oral Spray prepared using PBI's revolutionary Ultra Shear Technology™ (UltraShear™ or UST™) platform.
- ACCESSWIRE
Pressure BioSciences Gives Guidance for Strong Q4 2022 Sales Followed by Rapid Revenue Growth from Multiple Large Industries in 2023
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty process development and production services to the worldwide nutraceuticals, cosmetics, biotherapeutics, and food/beverage industries, among others, today offered guidance that the Company believes its Q4 2022 revenue will exceed quarterly revenue for any quarter over the
- ACCESSWIRE
Pressure BioSciences Announces First Commercial Production of Revolutionary UltraShear Nanoemulsion Product Shipped, Booked, and Paid
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty process development and production services to the worldwide nutraceuticals, cosmetics, biotherapeutics, and food/beverage industries, among others, today confirmed the shipment of the Company's first ever commercial production lot of a revolutionary nanoemulsion product created
- ACCESSWIRE
Pressure BioSciences Partnership with QVC Skincare Leader Dr. Denese SkinScience Yields Unprecedented Effectiveness in Skin Tightening and Wrinkle Reduction
Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty process development and production services to the worldwide cosmetics, nutraceuticals, biotherapeutics, and food/beverage industries, among others, today confirmed that initial results from their first stage of product development under PBI's August 2022 collaboration agreement
- Newsfile
Pressure BioSciences Securing and Fulfilling UltraShear Nanoemulsions Contracts, Discussed on "Stock Day Podcast"
Phoenix, Arizona--(Newsfile Corp. - December 5, 2022) - The Stock Day Podcast recently welcomed Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or "the Company"), a leader in the development and sale of innovative, broadly enabling, high-pressure-based instruments, consumables, and specialty process development and production services for the worldwide life sciences markets and other industries. PBI's CEO Mr. Richard T. Schumacher, joined Stock Day host Mr. Everett Jolly to explain and highlight